Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.
Alejandro Rodriguez, MD, assistant professor, Department of Obstetrics and Gynecology, University of South Florida Morsani College of Medicine, Tampa, Florida along with 3 other investigators, evaluated the impact of early glucose screening and treatment on high risk individuals.
Florida participants were chosen based on ACOG’s practice bulletin risk factors for GDM. Inclusion data included pregnant patients between 18 and 45 years of age with 1 or more of the following risk factors: obesity; history of prior pregnancy complicated by GDM; history of prior pregnancy complicated by macrosomia; first degree relative with diabetes; and multiple gestation.
Strengths of this study included that it was both randomized and clinical, which would add to the paucity of literature on this subject with standardized diagnosis and management plans.
Participants were randomized into 2 screening groups: glucose screen at 12-18 weeks’ (early) or at 24-28 weeks’ (usual care). Two-step screening was performed with gestational diabetes diagnosed using Carpenter−Coustan criteria. Women with a negative test at 12-18 weeks’ were rescreened at 24 to 28 weeks. All patients diagnosed with GDM were treated following institutional protocols.
Primary outcomes were a composite of adverse perinatal outcomes, including perinatal mortality; neonatal hypogkycemia; addmision to a NICU; hyperbilirubinemia; and birth trauma, with a secondary outcome of maternal gestational weight gain.
The authors concluded that early glucose screening in women at high risk for gestational diabetes was not associated with improved perinatal outcomes.
Reference
Rodriguez A, Delgado A, Pressman K, Louis JM. Early gestational diabetes screening in women at risk for gestational diabetes: a randomized controlled trial. Oral concurrent session. Society for Maternal-Fetal Medicine 42nd Annual Pregnancy Meeting. Virtual. February 4, 2022.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More